
Please try another search
IPO Listing | Company | Exchange | IPO Value | IPO Price | Last |
---|---|---|---|---|---|
IPO Listing | Company | Exchange | IPO Value | IPO Price | Last |
Feb 19, 2025 | Anbio Biotechnology Inc (NNNN) | NASDAQ | 8.0M | 5.00 | 6.69 |
Feb 20, 2025 | Nusatrip Inc (NUTR) | NASDAQ | 10.8M | 4.00 | 41.80 |
Feb 21, 2025 | Wellgistics Health Inc (WGRX) | NASDAQ | 4.1M | 4.50 | 2.70 |
Feb 23, 2025 | Apimeds Pharma US Ltd (APUS) | NYSE | 22.5M | 4.00-5.00 | 4.50 |
Feb 25, 2025 | Basel Medical Group (BMGL) | NASDAQ | 11.0M | 4.00 | 4.17 |
Feb 27, 2025 | Luda Tech Group Ltd (LUD) | NASDAQ | 10.0M | 4.00 | 4.06 |
Feb 27, 2025 | Lz Technology Holdings Corp (LZMH) | NASDAQ | 7.2M | 4.00 | 5.65 |
Feb 27, 2025 | Webus International Ltd (WETO) | NASDAQ | 8.0M | 4.00 | 3.76 |
Feb 28, 2025 | Fifth Era Acq I Corp (FERAU) | NASDAQ | 200.0M | 10.00 | 10.02 |
Feb 28, 2025 | Live Oak Acq V Corp (LOKVU) | NASDAQ | 200.0M | 10.00 | 10.02 |
Feb 28, 2025 | Rithm Acquisition Corp (RAC_u) | NYSE | 10.00 | 10.03 |
Singapore, March 03, 2025 (GLOBE NEWSWIRE) -- Basel Medical (TASE:BLWV) Group Ltd (the Company) (Nasdaq: BMGL), a Singapore-based clinical provider of general and...
HUZHOU CITY, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings Limited (NASDAQ: LZMH) (LZ Technology or the Company), an information technology and advertising...
Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic...
Singapore, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Basel Medical (TASE:BLWV) Group Ltd (the Company) (Nasdaq: BMGL), a Singapore-based clinical provider of general and...
Singapore, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Basel Medical (TASE:BLWV) Group Ltd (the Company) (Nasdaq: BMGL), a Singapore-based clinical provider of general and...
Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the Company or Anbio), a global diagnostic company dedicated to the advancement of medical...
Investing.com -- Anbio Biotechnology, a global diagnostic company, announced the pricing of its initial public offering (IPO) at $5.00 per Class A Ordinary Share. However, the...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking for 'win' or to...